ID   F98
AC   CVCL_3510
DR   CLO; CLO_0002992
DR   ATCC; CRL-2397
DR   BCRJ; 0085
DR   MetaboLights; MTBLS6212
DR   Wikidata; Q54833166
RX   PubMed=7435138;
RX   PubMed=12036929;
RX   PubMed=19381449;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   20FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
RX   PubMed=7435138; DOI=10.1007/BF00688846;
RA   Ko L., Koestner A., Wechsler W.;
RT   "Morphological characterization of nitrosourea-induced glioma cell
RT   lines and clones.";
RL   Acta Neuropathol. 51:23-31(1980).
//
RX   PubMed=12036929;
RA   Barth R.F., Yang W.-L., Adams D.M., Rotaru J.H., Shukla S., Sekido M.,
RA   Tjarks W., Fenstermaker R.A., Ciesielski M.J., Nawrocky M.M.,
RA   Coderre J.A.;
RT   "Molecular targeting of the epidermal growth factor receptor for
RT   neutron capture therapy of gliomas.";
RL   Cancer Res. 62:3159-3166(2002).
//
RX   PubMed=19381449; DOI=10.1007/s11060-009-9875-7; PMCID=PMC2730996;
RA   Barth R.F., Kaur B.;
RT   "Rat brain tumor models in experimental neuro-oncology: the C6, 9L,
RT   T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.";
RL   J. Neurooncol. 94:299-312(2009).
//